Document Detail

Treatment of keratoacanthomas with intralesional fluorouracil.
MedLine Citation:
PMID:  736584     Owner:  NLM     Status:  MEDLINE    
Fourteen patients with 26 keratoacanthomas (KA) were treated weekly with intralesional injections of fluorouracil. Twenty-five lesions cleared in an average of three weeks (range, two to eight weeks) after an average of 2.8 injections. One KA failed to respond after five weekly injections and was excised. No recurrences or meaningful side effects were observed. It appears that treatment of KA with intralesional fluorouracil injections is a safe, effective, and convenient mode ot treatment yielding excellent cosmetic results.
R B Odom; D K Goette
Related Documents :
20569284 - International consensus recommendations on the aesthetic usage of botulinum toxin type ...
11016734 - Radioguided surgery of breast cancer: radiation protection survey.
8291874 - Cavernous auto-injection therapy with prostaglandin e1.
2454304 - Glycerol rhizolysis for treatment of trigeminal neuralgia.
25303924 - Laparoscopic versus open resection for transverse colon cancer.
9627874 - Early and late postoperative alignment following unilateral lateral rectus recession fo...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Archives of dermatology     Volume:  114     ISSN:  0003-987X     ISO Abbreviation:  Arch Dermatol     Publication Date:  1978 Dec 
Date Detail:
Created Date:  1979-03-24     Completed Date:  1979-03-24     Revised Date:  2008-03-17    
Medline Journal Info:
Nlm Unique ID:  0372433     Medline TA:  Arch Dermatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1779-83     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fluorouracil / administration & dosage*,  therapeutic use
Keratoacanthoma / drug therapy*,  pathology
Middle Aged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fate of pemphigus antibody following successful therapy. Preliminary evaluation of pemphigus antibod...
Next Document:  Cutaneous plasmacytomas in myeloma. Relationship to tumor cell burden.